| For: |
Huang XH, Sun LH, Lu DD, Sun Y, Ma LJ, Zhang XR, Huang J, Yu L. Codon 249 mutation in exon 7 of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i4/692.htm |
| Number | Citing Articles |
| 1 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
| 2 |
Emily Crowley, Federica Di Nicolantonio, Fotios Loupakis, Alberto Bardelli. Liquid biopsy: monitoring cancer-genetics in the blood. Nature Reviews Clinical Oncology 2013; 10(8) doi: 10.1038/nrclinonc.2013.110
|
| 3 |
Muhammad Nur Adam Hatta, Ezanee Azlina Mohamad Hanif, Siok-Fong Chin, Hui-min Neoh. Pathogens and Carcinogenesis: A Review. Biology 2021; 10(6) doi: 10.3390/biology10060533
|
| 4 |
. 2020; doi: 10.70675/3e36074ezd0bez4f4czaaecz024eeb87f567
|
| 5 |
Shu-Qiang Yue, Yan-Ling Yang, Ke-Feng Dou, Kai-Zong Li. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis. World Journal of Gastroenterology 2003; 9(12): 2863-2865 doi: 10.3748/wjg.v9.i12.2863
|
| 6 |
Huai Wang, Peng Liao, Shelya X Zeng, Hua Lu. It takes a team: a gain-of-function story of p53-R249S. Journal of Molecular Cell Biology 2019; 11(4) doi: 10.1093/jmcb/mjy086
|
| 7 |
Jingjing Jiao, Weibo Niu, Ying Wang, Keith Baggerly, Yuanqing Ye, Xifeng Wu, Dewitt Davenport, Jose Luis Almeda, Monica M. Betancourt-Garcia, R. Armour Forse, Heather L. Stevenson, Gordon P. Watt, Joseph B. McCormick, Susan P. Fisher-Hoch, Laura Beretta. Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas. Cancer Prevention Research 2018; 11(2) doi: 10.1158/1940-6207.CAPR-17-0235
|
| 8 |
Filiz Türe Özdemir, Arzu Tiftikci, Seda Sancak, Fatih Eren, Veysel Tahan, Hakan Akın, Feyza Gündüz, Ala Eldeen Kedrah, Yücel Üstündağ, Erol Avşar, Nurdan Tözün, Osman Özdoğan. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey. Journal of Gastrointestinal Cancer 2010; 41(3) doi: 10.1007/s12029-010-9140-5
|
| 9 |
Peng Lee, Shilpa Jain, Matthew R. Pincus, Ruliang Xu. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; doi: 10.1016/B978-1-4377-0974-2.00076-2
|
| 10 |
Jian-Guo Chen, Thomas W. Kensler, Gui-Ju Sun, Jian Zhu, Jian-Hua Lu, Da Pan, Yong-Hui Zhang, John D. Groopman. Aflatoxin and Liver Cancer in China: The Evolving Research Landscape. Toxins 2026; 18(2) doi: 10.3390/toxins18020061
|
| 11 |
S. Anitha, D. Raghunadharao, F. Waliyar, H. Sudini, M. Parveen, Ratna Rao, P. Lava Kumar. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2014; 766 doi: 10.1016/j.mrgentox.2013.12.011
|
| 12 |
Vincent L. Chen, Neehar D. Parikh. Liquid Biopsy for Hepatocellular Carcinoma. Current Hepatology Reports 2019; 18(4) doi: 10.1007/s11901-019-00491-z
|
| 13 |
Ying-Hsiu Su, Selena Y Lin, Wei Song, Surbhi Jain. DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2014; 14(7) doi: 10.1586/14737159.2014.946908
|
| 14 |
Jia Jie Li, Yanqing Lv, Huifan Ji. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis. PeerJ 2022; 10 doi: 10.7717/peerj.14303
|
| 15 |
GERALD C KIMBI, MICHAEL C KEW, MIMI C YU, KAZUKO ARAKAWA, JOHN HODKINSON. 249serp53 mutation in the serum of black southern African patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2005; 20(8) doi: 10.1111/j.1440-1746.2005.03951.x
|
| 16 |
Paul W. Ewald, Holly A. Swain Ewald. Infection, mutation, and cancer evolution. Journal of Molecular Medicine 2012; 90(5) doi: 10.1007/s00109-012-0891-2
|
| 17 |
Jinmei Zhang, Yuan Yuan, Shuxia Gao, Xue Zhao, Hong Li. Diagnostic Performance of Circulating Cell-Free Dna for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Biomarkers in Medicine 2021; 15(3) doi: 10.2217/bmm-2020-0334
|
| 18 |
Jian Zhou, Ao Huang, Xin-Rong Yang. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2016; 47(2) doi: 10.1007/s12029-016-9801-0
|
| 19 |
Michael Torbenson, Rajesh Kannangai, Susan Abraham, Fikret Sahin, Michael Choti, Jianzhou Wang. Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular Carcinoma. American Journal of Clinical Pathology 2004; 122(3) doi: 10.1309/YH0H3FKYM4RMU1JF
|
| 20 |
Jingjing Jiao, Weibo Niu, Ying Wang, Keith Baggerly, Yuanqing Ye, Xifeng Wu, Dewitt Davenport, Jose Luis Almeda, Monica M. Betancourt-Garcia, R. Armour Forse, Heather L. Stevenson, Gordon P. Watt, Joseph B. McCormick, Susan P. Fisher-Hoch, Laura Beretta. Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas. Cancer Prevention Research 2018; 11(2) doi: 10.1158/1940-6207.CAPR-17-0235
|
| 21 |
Kailas D Datkhile, Rashmi Gudur, Madhavi N Patil, Anand Gudur. Interactive Association of XRCC1, XRCC2, XRCC3, and TP53 Gene Polymorphisms With Gastrointestinal Cancer Risk: Insights From a Hospital-Based Case-Control Study. Cureus 2024; doi: 10.7759/cureus.61921
|
| 22 |
Jian-Guo Chen, Yuan-Rong Zhu, Geng-Sun Qian, Jin-Bing Wang, Jian-Hua Lu, Thomas W. Kensler, Lisa P. Jacobson, Alvaro Muñoz, John D. Groopman. Fifty Years of Aflatoxin Research in Qidong, China: A Celebration of Team Science to Improve Public Health. Toxins 2025; 17(2) doi: 10.3390/toxins17020079
|
| 23 |
Fernanda Magri de Carvalho, Thiago de Almeida Pereira, Patrícia Lofego Gonçalves, Robson Dettmann Jarske, Fausto Edmundo Lima Pereira, Iuri Drumond Louro. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil. Molecular Biology Reports 2013; 40(8) doi: 10.1007/s11033-013-2587-2
|
| 24 |
Yunlong Cui, Hua Li, Hongjie Zhan, Tao Han, Yixuan Dong, Caijuan Tian, Yixian Guo, Fang Yan, Dong Dai, Pengfei Liu. Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.733478
|
| 25 |
Xiao-mo Wu, Jing-geng Fu, Wang-zhong Ge, Jiang-yan Zhu, Jun-yong Wang, Wei Zhang, Wei Qian, Ke-ke Huo. Screen p53 mutations in hepatocellular carcinoma by FASAY: A novel splicing mutation. Journal of Zhejiang University SCIENCE B 2007; 8(2) doi: 10.1631/jzus.2007.B0081
|
| 26 |
Xinghua Huang, Guoqing Ji, Yanhua Wu, Bo Wan, Long Yu. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. Journal of Cancer Research and Clinical Oncology 2008; 134(6) doi: 10.1007/s00432-007-0342-6
|
| 27 |
Yan Liu, Chung-Chou H. Chang, Gary M. Marsh, Felicia Wu. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. European Journal of Cancer 2012; 48(14) doi: 10.1016/j.ejca.2012.02.009
|
| 28 |
M. Fleischhacker, B. Schmidt. Circulating nucleic acids (CNAs) and cancer—A survey. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2007; 1775(1) doi: 10.1016/j.bbcan.2006.10.001
|
| 29 |
Klaus Jung, Michael Fleischhacker, Anja Rabien. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature. Clinica Chimica Acta 2010; 411(21-22) doi: 10.1016/j.cca.2010.07.032
|
| 30 |
Y.M. Dennis Lo, Rossa W.K. Chiu. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 2012; doi: 10.1016/B978-1-4160-6164-9.00045-7
|
| 31 |
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary Malignancies. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
|
| 32 |
Sherif A. El-Kafrawy, Mohamed Abdel-Hamid, Mai El-Daly, Ola Nada, Alaa Ismail, Sameera Ezzat, Soheir Abdel-Latif, Amany Abdel-Hamid, Peter G. Shields, Christopher Loffredo. p53 Mutations in hepatocellular carcinoma patients in Egypt. International Journal of Hygiene and Environmental Health 2005; 208(4) doi: 10.1016/j.ijheh.2005.02.002
|
| 33 |
Katarzyna Szymañska, Jian-Guo Chen, Yan Cui, Yun Yun Gong, Paul Craig Turner, Stéphanie Villar, Christopher Paul Wild, Donald Maxwell Parkin, Pierre Hainaut.
TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, China. Cancer Epidemiology, Biomarkers & Prevention 2009; 18(5) doi: 10.1158/1055-9965.EPI-08-1102
|
| 34 |
Rufina Igetei, Jesse A. Otegbayo, Dennis A. Ndububa, Olufunmilayo A. Lesi, Chiaka I. Anumudu, Pierre Hainaut, Emmanuelle Gormally. Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNA. Annals of Hepatology 2008; 7(4) doi: 10.1016/S1665-2681(19)31834-4
|
| 35 |
Jingjing Jiao, Jessica I. Sanchez, Erika J. Thompson, Xizeng Mao, Joseph B. McCormick, Susan P. Fisher-Hoch, P. Andrew Futreal, Jianhua Zhang, Laura Beretta. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147411
|
| 36 |
|
| 37 |
S. Saleem, Z. A. Abbasi, A. Hameed, N. R. Qureshi, M. A. Khan, A. Azhar. Novel p53 codon 240 Ser > Thr coding region mutation in the patients of oral squamous cell carcinoma (OSCC). Tumor Biology 2014; 35(8) doi: 10.1007/s13277-014-2062-2
|
| 38 |
HORST H. SCHLECHTE, CORNELIA STELZER, SABINE WEICKMANN, MICHAEL FLEISCHHACKER, GUNTRAM SCHULZE. TP53 Gene in Blood Plasma DNA of Tumor Patients. Annals of the New York Academy of Sciences 2004; 1022(1) doi: 10.1196/annals.1318.011
|
| 39 |
V. B. Weeda, D. C. Aronson, J. Verheij, W. H. Lamers. Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patients. Pediatric Blood & Cancer 2019; 66(2) doi: 10.1002/pbc.27475
|
| 40 |
K. Pandima Devi, B. Sivamaruthi, PV Kiruthiga, S. Karutha Pandian. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits. Human & Experimental Toxicology 2010; 29(6) doi: 10.1177/0960327109354938
|
| 41 |
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinoma. Translational Research 2018; 201 doi: 10.1016/j.trsl.2018.07.001
|